Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Human metabolism trial
Items per page
5
10
20
40
60
100
Title
Average Rating
Tumor pO(2) as a Surrogate Marker to Identify Therapeutic Window during Metronomic Chemotherapy of 9L Gliomas.
60.00%
Serum cytokines in pancreatic cancer: Correlation with outcome
40.00%
Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity...........
90.00%
p53 as a specific prognostic factor in triple-negative breast cancer.
75.00%
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder
60.00%
MET in small cell lung carcinoma (SCLC): Effects of a MET inhibitor in SCLC cell lines and prognostic role of MET status in pati
50.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid
55.00%
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro,
50.00%
High-Dose celecoxib and metronomic "low-dose" cyclophosphamide is an effective and safe therapy in patients with relapsed and re
70.00%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas.
63.33%
Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocy..
80.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies....
50.00%
Clinical studies of Ukrain in healthy volunteers (phase 1).
60.00%
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy
50.00%
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. Sub-category: Cell-Based Therapy
90.00%
CECs, CEPs and CTCs for prediction of response in patients with advanced breast cancer (ABC) receiving metronomic vinorelbine.
60.00%
c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of non
50.00%
Biophotonics in the infrared spectral range reveal acupuncture meridian structure of the body.
95.00%
Bioavailability of sorafenib tablets administered as a liquid suspension.
30.00%
Association between serum 25(OH)D and death from prostate cancer.
70.00%
A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients wi
60.00%
Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and
50.00%